Travere Therapeutics, Inc. data breach

Clerk's notes

Travere Therapeutics, Inc., a biopharmaceutical company, filed notice of a data breach with state regulators in New Hampshire on October 27, 2025. While specific details regarding the nature of the incident and the exact types of information involved remain under investigation, the company’s report indicates that personal information may have been compromised.

At this time, the breach is still under investigation, and the full scope of the incident, including the number of individuals affected, has not been publicly specified. Individuals who received a notification letter from Travere Therapeutics are encouraged to carefully review that communication for details pertinent to their situation.

If you have been notified by Travere Therapeutics about this data security incident, it is important to take proactive steps to protect your personal information. This includes reviewing any notices you received for specific advice and monitoring your financial accounts and credit reports for any suspicious activity.

While the investigation is ongoing, understanding your rights as an affected individual is critical. Data breach cases often involve complex legal considerations that vary depending on the specifics of the incident and the laws governing data privacy.

For those concerned about how this breach may affect them, a free case review can offer clarity. This process allows individuals to discuss their specific circumstances with a legal professional to evaluate potential options. It is important to note that initiating a case review does not establish an attorney-client relationship.

If a notification letter about this breach reached you, see every NH data breach on file or browse all cases.